Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational InvestigationReportar como inadecuado

Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

International Journal of Rheumatology - Volume 2015 2015, Article ID 178750, 6 pages -

Clinical Study

Hamad Medical Corporation, Department of Medicine, Doha, Qatar

Prince Sultan Military Medical Center, P.O. Box 5004, Riyadh 11422, Saudi Arabia

Department of Medicine, Faculty of Medicine, Kuwait University, P.O. Box 24923, 13110 Al-Safat, Kuwait

Rheumatology and Immunology Unit, Internal Medicine Department, Cairo University, Cairo 11562, Egypt

Pfizer Inc. Africa and Middle East, Dubai, UAE

Oregon Health and Science University, Portland, OR 97239, USA

Received 10 August 2015; Revised 2 November 2015; Accepted 16 November 2015

Academic Editor: Malcolm Smith

Copyright © 2015 Mohammed Hammoudeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Data on spondyloarthritis SpA from the Middle East are sparse and the management of these diseases in this area of the world faces a number of challenges, including the relevant resources to enable early diagnosis and referral and sufficient funds to aid the most appropriate treatment strategy. The objective was to report on the characteristics, disease burden, and treatment of SpA in the Middle East region and to highlight where management strategies could be improved, with the overall aim of achieving better patient outcomes. This multicenter, observational, cross-sectional study collected demographic, clinical, laboratory, and treatment data on 169 consecutive SpA patients at four centers Egypt, Kuwait, Qatar, and Saudi Arabia. The data collected presents the average time from symptom onset to diagnosis along with the presence of comorbidities in the region and comparisons between treatment with NSAIDs and biologics. In the absence of regional registries of SpA patients, the data presented here provide a rare snapshot of the characteristics, disease burden, and treatment of these patients, highlighting the management challenges in the region.

Autor: Mohammed Hammoudeh, Hanan Al Rayes, Adel Alawadhi, Kamel Gado, Khalid Shirazy, and Atul Deodhar



Documentos relacionados